The main battlefield of mRNA vaccine - Tumor immune microenvironment.

Li, Xiaolong; Ma, Shijie; Gao, Ting; Mai, Yaping; Song, Zhihua; Yang, Jianhong

Li, Xiaolong; Ma, Shijie; Gao, Ting; Mai, Yaping; Song, Zhihua; Yang, Jianhong.

Afiliación

Li X; Departmert of Pharmaceutics, School of Phammacy:Ningxia Medical University, No. 1160 Shengli South Street, Yinchuan 750004, PR China.
Ma S; Departmert of Pharmaceutics, School of Phammacy:Ningxia Medical University, No. 1160 Shengli South Street, Yinchuan 750004, PR China.
Gao T; Department of Preparation Center, General Hospital of Ningxia Medical University, No. 804 Shengli South Street, Yinchuan 750004, PR China.
Mai Y; Science and Technology Center, Ningxia Medical University, No. 1160 Shengli South Street, Yinchuan 750004, PR China.
Song Z; Department of Clinical Pharmacy Center of Nanfang Hospital Southern Medical Univerisity, Guangzhou, Guangdong 510515, PR China. Electronic address: 65709728@qq.com.
Yang J; Departmert of Pharmaceutics, School of Phammacy:Ningxia Medical University, No. 1160 Shengli South Street, Yinchuan 750004, PR China. Electronic address: pharmacyy217@163.com.

Int Immunopharmacol ; 113(Pt A): 109367, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36327875

Asunto(s)

Vacunas contra el Cáncer; Neoplasias; Humanos; Microambiente Tumoral; Inmunoterapia; Vacunas Sintéticas; Neoplasias/metabolismo; Vacunas de ARNm

Palabras clave

Adjuvant; Metastasis; TIME; Tumor; mRNA vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Neoplasias Límite: Humans Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google